DTC — Defence Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00
- CA$56.92m
- CA$58.08m
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -0.002 | -0.673 | -2.86 | -7.34 | -6.76 |
Depreciation | |||||
Amortisation | |||||
Deferred Taxes | |||||
Non-Cash Items | 0 | 0.493 | 0.606 | 0.371 | 0.558 |
Other Non-Cash Items | |||||
Changes in Working Capital | -0.001 | 0.048 | -0.036 | 0.928 | -1.36 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Cash from Operating Activities | -0.003 | -0.133 | -2.29 | -6.04 | -7.66 |
Capital Expenditures | 0 | -0.046 | — | — | -0.066 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Cash from Investing Activities | 0 | -0.046 | — | — | -0.066 |
Financing Cash Flow Items | 0 | -0.233 | -0.564 | 0 | -0.588 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0 | 2.04 | 5.88 | 1.1 | 10 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.003 | 1.87 | 3.59 | -4.95 | 2.29 |